BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Argos Therapeutics, Inc. (Formerly Merix Bioscience) 

4233 Technology Drive

Durham  North Carolina  27704  U.S.A.
Phone: 919-287-6300 Fax: 919-287-6301


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Duke University  Exclusive license to the RNA based vaccine technology.

Rockefeller University  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

Baylor University  Clinical and preclinical research in Lupus.

Kirin Brewery Co., Ltd.  The companies will collaborate to develop and commercialize dendritic cell vaccines, initially in the areas of cancer and infectious diseases.

Erlangen University  Clinical and preclinical research in Melanoma.





 Company News
Argos Therapeutics, Inc. (ARGS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/1/2014 9:00:36 AM
Argos Therapeutics, Inc. (ARGS) Enters Into $25 Million Venture Loan Facility Led By Horizon Technology Finance 9/30/2014 8:25:13 AM
Argos Therapeutics, Inc. (ARGS) To Present At The 21st Annual Biocentury Newsmakers Conference 9/19/2014 7:20:27 AM
Enrollment In Argos Therapeutics, Inc. (ARGS)' Pivotal Phase 3 ADAPT Trial Of AGS-003 For Metastatic Renal Cell Carcinoma Surpasses Fifty Percent 9/18/2014 7:40:31 AM
Argos Therapeutics, Inc. (ARGS) Announces Issuance Of Arcelis® Technology Platform Patent 9/8/2014 10:12:10 AM
Argos Therapeutics, Inc. (ARGS) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/3/2014 7:50:34 AM
Argos Therapeutics, Inc. (ARGS) Commits To New Headquarters In Durham 8/25/2014 7:29:16 AM
Argos Therapeutics, Inc. (ARGS) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/13/2014 4:00:01 PM
Argos Therapeutics, Inc. (ARGS) To Hold Second Quarter 2014 Financial Results Conference Call On Wednesday, August 13, 2014 8/6/2014 10:03:29 AM
Argos Therapeutics, Inc. (ARGS) Presents Data Showing The Impact Of HIV Antigen Sequence Divergence On Durable Viral Control Following Treatment With Autologous Immune Therapy 7/22/2014 10:41:31 AM
12345678910...